FDA Approves First Generic Exparel – But What Will The Courts Say?
ANDA Holder eVenus Predicted To Settle; Potential For 2041 US Launch Or Later
Despite the first and only US FDA approval, Jiangsu Hengrui’s US eVenus has been tipped to stay out of the generic Exparel market until at least the end of the 2030s. Generics Bulletin investigates.
